ENROLLED 2023 Legislature CS for SB 612 2023612er 1 2 An act relating to the blood clot and pulmonary 3 embolism policy workgroup; providing a short title; 4 creating s. 408.0621, F.S.; requiring the Secretary of 5 Health Care Administration, in conjunction with the 6 State Surgeon General, to establish a blood clot and 7 pulmonary embolism policy workgroup; providing for the 8 duties, membership, and meetings of the workgroup; 9 requiring the secretary to submit annual reports to 10 the Governor and the Legislature; requiring the 11 secretary to submit a final report to the Governor and 12 the Legislature by a specified date; providing an 13 effective date. 14 15 Be It Enacted by the Legislature of the State of Florida: 16 17 Section 1. This act may be cited as the “Emily Adkins 18 Prevention Act.” 19 Section 2. Section 408.0621, Florida Statutes, is created 20 to read: 21 408.0621 Blood clot and pulmonary embolism policy 22 workgroup.— 23 (1) The Secretary of Health Care Administration, in 24 conjunction with the State Surgeon General, shall establish a 25 blood clot and pulmonary embolism policy workgroup. 26 (2) The workgroup shall: 27 (a) Identify the aggregate number of people who experience 28 blood clots and pulmonary embolisms each year in this state. 29 (b) Identify how data is collected regarding blood clots, 30 pulmonary embolisms, and adverse health outcomes associated with 31 these conditions. 32 (c) Identify how blood clots and pulmonary embolisms impact 33 the lives of people in this state. 34 (d) Identify the standards of care for blood clot 35 surveillance, detection, and treatment. 36 (e) Identify emerging treatments, therapies, and research 37 relating to blood clots. 38 (f) Develop a risk surveillance system to help health care 39 providers identify patients who may be at a higher risk of 40 forming blood clots and pulmonary embolisms. 41 (g) Develop policy recommendations to help improve patient 42 awareness of blood clot risks. 43 (h) Develop policy recommendations to help improve 44 surveillance and detection of patients who may be at a higher 45 risk of forming blood clots in licensed health care facilities, 46 including, hospitals, nursing homes, assisted living facilities, 47 residential treatment facilities, and ambulatory surgical 48 centers. 49 (i) Develop policy recommendations relating to guidelines 50 used that affect the standard of care for patients at risk of 51 forming blood clots. 52 (j) Develop policy recommendations relating to providing 53 patients and their families with written notice of increased 54 risks of forming blood clots. 55 (3)(a) The workgroup shall be composed of health care 56 providers, patients who have experienced blood clots, family 57 members of patients who have died from blood clots, advocates, 58 and other interested parties and associations. 59 (b) The President of the Senate and the Speaker of the 60 House of Representatives shall each appoint two members to the 61 workgroup. 62 (c) Members of the workgroup shall serve without 63 compensation. 64 (d) The State Surgeon General shall appoint the chair of 65 the workgroup. 66 (e) The chair is authorized to create subcommittees to help 67 with research, scheduling speakers on important subjects, and 68 drafting a workgroup report and policy recommendations. 69 (f) Meetings of the workgroup may be held through 70 teleconference or other electronic means. 71 (4)(a) The Secretary of Health Care Administration shall 72 submit an annual report detailing his or her findings and 73 recommendations to the Governor, the President of the Senate, 74 and the Speaker of the House of Representatives. 75 (b) The Secretary of Health Care Administration shall 76 submit a final report detailing his or her findings and 77 recommendations to the Governor, the President of the Senate, 78 and the Speaker of the House of Representatives by January 4, 79 2025. 80 Section 3. This act shall take effect July 1, 2023.